Literature DB >> 11092795

Quality of life measures: use and abuse.

D L Scott1, T Garrood.   

Abstract

Health status and quality of life measures are widely used in the clinical assessment of rheumatoid and other forms of arthritis. A range of measures is available, mainly as self-administered instruments. Most of these are reliable, valid and sensitive to change. They can be used to assess clinical status, evaluate effectiveness in randomized trials, define outcome and help to plan for health-care needs for people with arthritis. The instruments form a continuum with assessments of disease activity and functional disability. Some instruments are specifically designed for use in rheumatoid arthritis, other instruments are generic and can be used across a range of conditions including arthritis, and some generic instruments can be specifically scored to reflect the problems most prominent in arthritis. There are trade-offs between simplicity and sensitivity and between using familiar and unusual instruments. Against this background, the most widely used disease-specific measure remains the health assessment questionnaire (HAQ), and the most commonly employed generic measure is the SF-36. Evidence currently suggests focusing on these well-known and widely used measures. In both cases, the pain score is the predominant clinical assessment associated with poor health status measured using either instrument. HAQ scores also reflect unchanging aspects of patients' overall status, such as their degree of deprivation. It is sensible for all future clinical trials to include one disease-specific and one generic measure of health status. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11092795     DOI: 10.1053/berh.2000.0106

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  18 in total

1.  Functional limitations and well-being in injured municipal workers: a longitudinal study.

Authors:  Marion Gillen; Sarah A Jewell; Julia A Faucett; Edward Yelin
Journal:  J Occup Rehabil       Date:  2004-06

2.  Quality of life assessments with SF 36 in different musculoskeletal diseases.

Authors:  Figen Yilmaz; Fusun Sahin; Ernur Ergoz; Emel Deniz; Cem Ercalik; Serap Dalgic Yucel; Banu Kuran
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 2.980

3.  Impact of musculoskeletal pain on physical function and health-related quality of life in a rural community in south India: a WHO-ILAR-COPCORD-BJD India study.

Authors:  Ashish Jacob Mathew; Arvind Chopra; Dany Varughese Thekkemuriyil; Elizabeth George; Vinay Goyal; Jayakumar Bhaskaran Nair
Journal:  Clin Rheumatol       Date:  2011-08-19       Impact factor: 2.980

4.  Proxy assessment of quality of life in pediatric clinical trials: application of the Health Utilities Index 3.

Authors:  Cheryl L Cox; Shelly Lensing; Shesh N Rai; Pam Hinds; Elizabeth Burghen; Ching-Hon Pui
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

5.  Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study.

Authors:  Lydia Abasolo; Jose Ivorra-Cortes; Leticia Leon; Juan A Jover; Benjamín Fernández-Gutiérrez; Luis Rodriguez-Rodriguez
Journal:  Clin Rheumatol       Date:  2018-10-16       Impact factor: 2.980

6.  Impact of musculoskeletal disorders on quality of life: an inception cohort study.

Authors:  C H Roux; F Guillemin; S Boini; F Longuetaud; N Arnault; S Hercberg; S Briançon
Journal:  Ann Rheum Dis       Date:  2004-12-02       Impact factor: 19.103

Review 7.  [Measuring disease activity for rheumatoid arthritis].

Authors:  D Aletaha; T Stamm; J Smolen
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 8.  Quality of life in patients with rheumatoid arthritis : which drugs might make a difference?

Authors:  Barbara Blumenauer; Ann Cranney; Jennifer Clinch; Peter Tugwell
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Dental anxiety and oral health-related quality of life in aggressive periodontitis patients.

Authors:  Liran Levin; Avraham Zini; Jonathan Levine; Maor Weiss; Ron A Lev; Avihai Hai; Daniella Chebath-Taub; Galit Almoznino
Journal:  Clin Oral Investig       Date:  2017-10-11       Impact factor: 3.573

10.  Cost-utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting.

Authors:  Taru A Hallinen; Erkki J O Soini; Kari Eklund; Kari Puolakka
Journal:  Rheumatology (Oxford)       Date:  2010-01-25       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.